Literature DB >> 18598882

[AMBIZYGO: phase II study of high dose liposomal amphotericin B (AmBisome) [10 mg/kg/j] efficacy against zygomycosis].

F Lanternier1, O Lortholary.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18598882     DOI： 10.1016/S0399-077X(08)73003-8

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN： 0399-077X            Impact factor:   2.152


× No keyword cloud information.
  5 in total

1.  Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies.

Authors:  Maheen Z Abidi; Muhammad R Sohail; Nathan Cummins; Mark Wilhelm; Nancy Wengenack; Lisa Brumble; Harshal Shah; Donna Jane Hata; Ann McCullough; Amy Wendel; Holenarasipur R Vikram; Shimon Kusne; Mark Litzow; Louis Letendre; Brian D Lahr; Eric Poeschla; Randall C Walker
Journal:  Mycoses       Date:  2014-07-18       Impact factor: 4.377

Review 2.  Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.

Authors:  Neil R H Stone; Tihana Bicanic; Rahuman Salim; William Hope
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

3.  Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents.

Authors:  Matthew A Miller; Kyle C Molina; Jonathan A Gutman; Sias Scherger; Jessica M Lum; Sherif B Mossad; Mary Burgess; Matthew P Cheng; Sally T Chuang; Samantha E Jacobs; Dante P Melendez; Dimpy P Shah; Andrea Zimmer; M Rizwan Sohail; Sadia Syed; Randall C Walker; Eric M Poeschla; Maheen Z Abidi
Journal:  Open Forum Infect Dis       Date:  2020-12-30       Impact factor: 3.835

Review 4.  Role of New Antifungal Agents in the Treatment of Invasive Fungal Infections in Transplant Recipients: Isavuconazole and New Posaconazole Formulations.

Authors:  Julius Li; Cynthia T Nguyen; Julia Garcia-Diaz
Journal:  J Fungi (Basel)       Date:  2015-10-15

Review 5.  Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.

Authors:  Jeffrey D Jenks; Helmut Jf Salzer; Juergen Prattes; Robert Krause; Dieter Buchheidt; Martin Hoenigl
Journal:  Drug Des Devel Ther       Date:  2018-04-30       Impact factor: 4.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.